Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells. - Wikidata - wikimedia - TriplyDB

Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells.

Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells.

http://www.wikidata.org/entity/Q38360120

about

The regulation of inflammatory pathways and infectious disease of the cervix by seminal fluid Antitumor and antiangiogenic activities of curcumin in cervical cancer xenografts in nude mice.hrHPV E5 oncoprotein: immune evasion and related immunotherapies.Gene silencing of A-kinase anchor protein 4 inhibits cervical cancer growth in vitro and in vivo.The E5 proteins Link between chronic inflammation and human papillomavirus-induced carcinogenesis (Review).Papillomavirus E5: the smallest oncoprotein with many functions.HPV16 E5 deregulates the autophagic process in human keratinocytes.The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses.Seminal plasma enhances cervical adenocarcinoma cell proliferation and tumour growth in vivo.Effects of Tetrahydrocurcumin on Tumor Growth and Cellular Signaling in Cervical Cancer Xenografts in Nude Mice GW627368X inhibits proliferation and induces apoptosis in cervical cancer by interfering with EP4/EGFR interactive signaling Nip the HPV encoded evil in the cancer bud: HPV reshapes TRAILs and signaling landscapes Regulation of inflammatory pathways in cancer and infectious disease of the cervix Phosphatase and tensin homologue on chromosome 10 (PTEN) directs prostaglandin E2-mediated fibroblast responses via regulation of E prostanoid 2 receptor expression Emerging biological treatments for uterine cervical carcinoma.Human papillomavirus early proteins and apoptosis.Human papillomavirus oncoproteins and apoptosis (Review).HPV 16 E5 oncoprotein is expressed in early stage carcinogenesis and can be a target of immunotherapy.HPV16 E5 expression induces switching from FGFR2b to FGFR2c and epithelial-mesenchymal transition.Human papillomavirus type 16 E5 protein inhibits hydrogen-peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells.Artesunate exerts an anti-immunosuppressive effect on cervical cancer by inhibiting PGE2 production and Foxp3 expression.Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value.Human papillomavirus E5 oncoprotein: function and potential target for antiviral therapeutics

P2860

Q27024447-138DB5C1-1972-42A7-A628-40732E6F7EF5 Q33563034-53FC9613-6487-465B-96E5-A72C8580436C Q33730462-EA7EBC8F-03BE-4353-8117-C762C5F0C5F9 Q34350690-8E2B36D4-AB09-4989-9668-963C363CE236 Q34754347-8A891446-7A75-43A5-A539-3FEC04D0860E Q35042272-F7E1DCF2-0F4D-407A-BB96-D8F167428128 Q35642759-FB9022E7-5D69-4283-B2B0-18CDFF1845B2 Q35832368-D8707267-A112-4292-981B-CE27C2220438 Q35838573-150DB470-C270-4189-B4C2-824D50FE2044 Q35839966-BE7A6E02-C226-49E4-9A2B-E7A6ACD8B5AF Q36530104-495A6B12-A50C-440A-AA17-9B794EF8AF8F Q36775030-142D6DBE-3618-4321-876D-D88084228B35 Q36952911-E101A998-05A3-4E9F-8DBF-702CC222AEA6 Q37288090-DD891D0C-67B0-4341-8E0D-F6057C4DA635 Q37431908-EB9246A4-D16D-40EA-8FBF-70F3634E1A76 Q37540968-1D634F25-86C0-41C5-876B-662C293EF28C Q38069444-2C1A79DC-A82E-4F10-B1CC-570241AA0A1E Q38172151-A02C5EA8-B7A4-4075-A47E-A0E7E413CF88 Q38727142-CB8178B9-8C33-4DF8-B574-5F9E119FFB04 Q38934698-C352E1D6-09C1-4EE2-BBAC-2A5FCA151461 Q39762451-B840473A-18A1-474C-A57A-B3C1C4BE15C0 Q46204104-BF66100D-E53F-4B21-AC83-05C3D4C9C501 Q53275556-6C3F5683-9370-4645-AB10-6BEADC38E78C Q58420548-5436258A-ED9E-460B-8522-85B263C249B7

P2860

Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells.

http://www.wikidata.org/entity/Q38360120

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Human papillomavirus E5 protei ...... ways in cervical cancer cells.

@en

type

label

Human papillomavirus E5 protei ...... ways in cervical cancer cells.

@en

prefLabel

Human papillomavirus E5 protei ...... ways in cervical cancer cells.

@en

P1433

Q38360120-2DCF33D9-2717-4C19-9CBA-27E74DF51E22

P1476

Q38360120-AE919387-1ADE-45D2-97C8-EA9C027BEA72

P2093

Q38360120-2337DA85-2184-40A6-BEF9-317027215119

Q38360120-46B79F36-D996-4AD1-A992-7E389A91A850

Q38360120-48C4D173-34DB-4D09-8B00-A21E22CFDB21

Q38360120-798AF94B-C005-4107-AA19-29ABA4043FDA

Q38360120-7C3E73EB-F3C2-4A2F-A60E-B0A4ABAA7368

Q38360120-A8FC7197-B1B9-4CE4-9292-0C2152238E47

Q38360120-AE3EB503-965C-4670-A61A-31EC644DD32B

Q38360120-B8BA5080-6469-4C0E-8C00-611ADC53E17C

P2860

Q38360120-03272D30-87D0-46BB-8CAA-3B641605DE5B

Q38360120-079507BF-BA7E-47D4-A26E-A3F1406E9D5A

Q38360120-0D7D69E5-0049-4D78-84D4-234F2456B8BB

Q38360120-0FD67B42-0EF9-40FE-84A1-60962D0C808F

Q38360120-184B8ADE-A317-448D-A2AB-BA6DD901F4EB

Q38360120-2B8BE819-E03D-4C23-B858-642DF9F6EF3D

Q38360120-3E8CE5E7-7447-4616-ACF9-4D9ECB7E6EA3

Q38360120-4348649D-2200-4390-9D54-072305059A5C

Q38360120-4C692611-66A9-4824-9422-0A406AAA562C

Q38360120-5540E788-ACE9-420C-BA43-FAAB8B277664

P304

Q38360120-B72732A7-7E4F-4E00-BE46-CE3C6906F1CC

P31

Q38360120-CF3DA843-C9D5-46F9-9EA4-956B3ED27352

P356

Q38360120-FF9C9C82-8F24-47B9-A627-1CD616B31159

P407

Q38360120-CD6B9901-E13D-4BA5-87E0-8B5BF3D0D914

P433

Q38360120-CAFC3A1E-CB00-428B-BF17-218F82B3ECC1

P478

Q38360120-6B27933E-92F7-48C5-A65D-0A9770B69902

P577

Q38360120-6C0683B2-7565-4E8A-B9A4-5B495365061C

P5875

Q38360120-08A6DD9E-C3F3-4B5A-AA67-0FE1E66DF3A9

P698

Q38360120-23C7121D-0ED3-4C96-B522-D8AF2A355F62

P356

P1433

P1476

Human papillomavirus E5 protei ...... ways in cervical cancer cells.

@en

P2093

Jung-Min Oh

http://www.w3.org/2001/XMLSchema#string

Miran Seo

http://www.w3.org/2001/XMLSchema#string

So-Young Kim

http://www.w3.org/2001/XMLSchema#string

Su-Hyeong Kim

http://www.w3.org/2001/XMLSchema#string

Woo-Ho Kim

http://www.w3.org/2001/XMLSchema#string

Yong-Sang Song

http://www.w3.org/2001/XMLSchema#string

Yong-Sung Juhnn

http://www.w3.org/2001/XMLSchema#string

Yun-Il Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors

Cycloxygenase-2 is expressed in vasculature of normal and ischemic adult human kidney and is colocalized with vascular prostaglandin E2 EP4 receptors

CREB--a real culprit in oncogenesis

The CGTCA sequence motif is essential for biological activity of the vasoactive intestinal peptide gene cAMP-regulated enhancer.

Human papillomavirus 16 E5 oncogene contributes to two stages of skin carcinogenesis

Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues.

Prostaglandin E(2) regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 beta-treated human synovial fibroblasts.

Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2.

Cyclooxygenase-2 induction by bradykinin in human pulmonary artery smooth muscle cells is mediated by the cyclic AMP response element through a novel autocrine loop involving endogenous prostaglandin E2, E-prostanoid 2 (EP2), and EP4 receptors.

Human papillomaviruses.

P304

141-149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CARCIN/BGN236

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23312032

http://www.w3.org/2001/XMLSchema#string

P698

18849297

http://www.w3.org/2001/XMLSchema#string